What is Pro Medicus Limited (PMEau)?
Pro Medicus Limited is an Australian company specializing in healthcare information technology. It develops and provides advanced medical imaging software solutions designed to improve diagnostic workflows and clinical decision-making. The company’s products facilitate the management, visualization, and distribution of medical images across healthcare networks. Pro Medicus serves hospitals, imaging centers, and healthcare providers globally, integrating its software with various imaging modalities and health information systems. Its offerings include picture archiving and communication systems (PACS) and vendor-neutral archives (VNA). The company emphasizes innovation and interoperability to support efficient healthcare delivery and patient care. Pro Medicus operates within the health IT sector, contributing to the digitization and optimization of medical imaging services.
Pro Medicus Limited Stock Price Today: Live Overview
The price today is shaped by active market fluctuations as Pro Medicus Limited stands at A$117.69. Its intraday price moved between A$116.49 and A$118.77, resulting in a daily change of -1.2456%.
FAQ: Pro Medicus Limited (PMEau)
What is the current price of PMEau stock?
The current price stands at A$117.69.
Does PMEau pay dividends?
Pro Medicus Limited pays dividends via cash distributions (if applicable).
Does PMEau have a formal corporate presence or regional headquarters in the UAE?
Pro Medicus Limited operates in the UAE through partnerships and distributors without an official office or subsidiary.
What is PMEau best known for?
Pro Medicus Limited is most famous for its medical imaging software solutions.
What assets are typically shown together with PMEau?
Commonly shown alongside PMEau: Range Nuclear Renaissance Index ETF, Pathward Financial Inc, Aramex PJSC
Latest shares articles



